Mor George Adi's Form 4 filing
Chemomab Therapeutics Ltd.CMMB · filed Jun 1, 2026
- Accession no.
- 0001178913-26-003004
- Filed
- Jun 1, 2026
- Trade date
- May 29, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $20.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mor George AdiCIK 0001851069 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | American Depositary Shares | PPurchaseDisposed | −4,878 | $2.05 | −$9,999.9 | 134,205 | Direct | |
| May 29, 2026 | American Depositary Shares | PPurchaseDisposed | −4,926 | $2.08 | −$10,246.08 | 139,131 | Direct | |
| May 29, 2026 | American Depositary Shares | JOtherDisposed | −31,712 | –F1 | – | 31,712 | Direct | |
| May 29, 2026 | American Depositary Shares | JOtherDisposed | −18,750 | –F1 | – | 18,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Referenced by the price of 2 transactions in Table I.